HRT Financial’s Syndax Pharmaceuticals SNDX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $1.19M | Sell |
127,111
-17,923
| -12% | -$168K | 0.01% | 995 |
|
2025
Q1 | $1.78M | Buy |
145,034
+40,154
| +38% | +$493K | 0.01% | 731 |
|
2024
Q4 | $1.39M | Buy |
104,880
+51,454
| +96% | +$680K | 0.01% | 786 |
|
2024
Q3 | $1.03M | Buy |
+53,426
| New | +$1.03M | 0.01% | 1139 |
|
2023
Q4 | – | Sell |
-24,009
| Closed | -$348K | – | 2789 |
|
2023
Q3 | $348K | Buy |
24,009
+13,258
| +123% | +$192K | ﹤0.01% | 1415 |
|
2023
Q2 | $225K | Buy |
+10,751
| New | +$225K | ﹤0.01% | 1609 |
|
2022
Q2 | – | Sell |
-43,145
| Closed | -$749K | – | 3475 |
|
2022
Q1 | $749K | Buy |
+43,145
| New | +$749K | 0.01% | 1132 |
|